New UAE deal is with Fine Hygienic Group, a FMCG company that according to Forbes has top 10 brand recognition in the Middle East. The company is doing US$1bn in sales, with a dominant position in toiletries (tissue / toilet paper). CEO was previously part of the senior leadership team at Procter & Gamble.

Recent pivot by the company into masks this year has seen millions of masks sold. Emboldened by its success in adjacent products, Fine has launched a full line of Zoono products as seen here:

Fine Guard Disinfectants | TheFineShop.com

The goal is for UAE (home market) launch initially next year, in all supermarkets and pharmacies, supported by a large advertising campaign.

This will be followed by rollout across 70 countries over the next 2 years.

Gross margins are north of 50%, so each dollar of Zoono sold will add $0.50c+ to Zoono's EBIT line.  No additional opex or capex is required to fulfil this contract.

First year sales of NZ$20m+ will equate to NZ$10m+ in extra EBIT.

Conservatively valuing this at 10x EBIT, the deal just added NZ$100m of shareholder value.

Probably of success is quite high IMO coz Fine is a proven brand in the Middle East. Top 10 brand in the minds of consumers would rank it equivalent to a Mars, or a Colgate in MENA. 

As mentioned in the AGM, Zoono has recently signed a deal to white-label its products with Fine Hygienic Group Holdings to rollout its products in 70 countries.

This group is one of the pre-eminent FMCG companies in the Middle East and North Africa.

Forbes Magazine has named Fine the ninth most recognized brand in the MENA region, underscoring the incredible strength of the brand in the minds of consumers.

Because Zoono's products are alcohol-free, they can be Halal-certified and this is a massive competitive advantage against incumbent products, for a mostly Muslim consumer base. 

Also, with Fine's brand, 3500+ staff & 70-year history in the region, they have the infrastructure and marketing budget to implement a consumer strategy that Zoono is incapable of doing on its own.

The CEO of Fine Group has worked for Procter & Gamble for 24 years and is an Olympic coach & a marathon runner. Quite a determined bloke.

In terms of financials, its possible to envisage $5-10m within a year or two at a 50%+ gross margin (lower GP% but offset by large volume & no additional opex commitment). A bull case could see Zoono selling $30-40m per annum if the products are successful, which will add $15-20m+ in incremental EBIT per annum.

#dividend

Are there any other companies that announce their maiden / inaurgural dividend without fanfare, but simply putting the record date and payment dates for the dividend inside a 'notice of FY20 full year results and key dates' announcement? 

ZNO has mastered the art of being subtle.